发明名称 ISOQUINOLINE AMIDE DERIVATIVE
摘要 <p>[Problem] To provide an excellent therapeutic or prophylactic agent for dementia, schizophrenia, and the like, which is based on a serotonin 5-HT5A receptor-modulating action. [Solution] The present invention was realized by discovering that an isoquinoline derivative, wherein a ring group is bonded to position 1 of the isoquinoline ring and a ring group or the like is further bonded to position 7 of the isoquinoline ring via a linking group having an amide group, has a potent 5-HT5A receptor-modulating action and an excellent pharmacological action based on that action, and by finding that the derivative is effective as a prophylactic or therapeutic agent for dementia, schizophrenia, and the like.</p>
申请公布号 WO2012108490(A1) 申请公布日期 2012.08.16
申请号 WO2012JP52936 申请日期 2012.02.09
申请人 ASTELLAS PHARMA INC.;HAMAGUCHI, WATARU;KOGANEMARU, YOHEI;SEKIOKA, RYUICHI;KANEKO, OSAMU;KATO, KOJI 发明人 HAMAGUCHI, WATARU;KOGANEMARU, YOHEI;SEKIOKA, RYUICHI;KANEKO, OSAMU;KATO, KOJI
分类号 C07D217/22;A61K31/472;A61K31/4725;A61K31/496;A61K31/497;A61K31/501;A61K31/506;A61K31/5377;A61K31/5383;A61P25/18;A61P25/20;A61P25/24;A61P25/28;A61P43/00;C07D401/12;C07D401/14;C07D405/12;C07D405/14;C07D409/12;C07D413/12;C07D417/12;C07D451/02;C07D453/02;C07D471/04;C07D487/04;C07D498/04 主分类号 C07D217/22
代理机构 代理人
主权项
地址